The Effect of Transient Increases in Kynurenic Acid and Quinolinic Acid Levels Early in Life on Behavior in Adulthood: Implications for Schizophrenia

Por Iaccarino, Hannah F., Suckow, Raymond F., Xie, Shan, Bucci, David J.
Publicado em 2013

Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA(A) receptors

Por Benham, Rebecca S., Hewage, Nishani B., Suckow, Raymond F., Engin, Elif, Rudolph, Uwe
Publicado no Behav Brain Res (2017)

Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood

Por Akagbosu, Cynthia O., Evans, Gretchen C., Gulick, Danielle, Suckow, Raymond F., Bucci, David J.
Publicado em 2012

Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice

Por Hodes, Georgia E., Hill-Smith, Tiffany E., Suckow, Raymond F., Cooper, Thomas B., Lucki, Irwin
Publicado em 2010

Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [(11)C] NNC112 and [(11)C] raclopride

Por Slifstein, Mark, Suckow, Raymond F, Javitch, Jonathan A, Cooper, Thomas, Lieberman, Jeffrey, Abi-Dargham, Anissa
Publicado em 2011

Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model

Por Sershen, Henry, Hashim, Audrey, Dunlop, David S., Suckow, Raymond F., Cooper, Tom B., Javitt, Daniel C.
Publicado no Neurochem Res (2016)

Clozapine Interaction with Phosphatidyl Inositol 3-Kinase (PI3K)/Insulin Signaling Pathway in Caenorhabditis elegans

Por Karmacharya, Rakesh, Sliwoski, Gregory R., Lundy, Miriam Y., Suckow, Raymond F., Cohen, Bruce M., Buttner, Edgar A.
Publicado em 2009

Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling

Por Balla, Andrea, Dong, Bin, Shilpa, Borehalli M., Vemuri, Kiran, Makriyannis, Alexandros, Pandey, Subhash C., Sershen, Henry, Suckow, Raymond F., Vinod, K. Yaragudri
Publicado no Neuropharmacology (2017)

High dose D-serine in the treatment of schizophrenia

Por Kantrowitz, Joshua T., Malhotra, Anil K., Cornblatt, Barbara, Silipo, Gail, Balla, Andrea, Suckow, Raymond F., D’Souza, Cyril, Saksa, John, Woods, Scott W., Javitt, Daniel C.
Publicado em 2010

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans

Por Driesen, Naomi R., McCarthy, Gregory, Bhagwagar, Zubin, Bloch, Michael, Calhoun, Vincent, D’Souza, Deepak C., Gueorguieva, Ralitza, He, George, Ramachandran, Ramani, Suckow, Raymond F., Anticevic, Alan, Morgan, Peter T., Krystal, John H.
Publicado em 2013

The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

Por Driesen, Naomi R, McCarthy, Gregory, Bhagwagar, Zubin, Bloch, Michael H, Calhoun, Vincent D, D'Souza, Deepak C, Gueorguieva, Ralitza, He, George, Leung, Hoi-Chung, Ramani, Ramachandran, Anticevic, Alan, Suckow, Raymond F, Morgan, Peter T, Krystal, John H
Publicado em 2013

A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder

Por Milak, Matthew S., Proper, Caitlin J., Mulhern, Stephanie T., Parter, Amy L., Kegeles, Lawrence S., Ogden, R. Todd, Mao, Xiangling, Rodriguez, Carolyn I., Oquendo, Maria A., Suckow, Raymond F., Cooper, Thomas B., Keilp, John C., Shungu, Dikoma C., Mann, J. John
Publicado no Mol Psychiatry (2015)